Skip to content

Effect of esketamine on the recovery time from sevoflurane anesthesia in children: a randomized controlled clinical study

Effect of esketamine on the recovery time from sevoflurane anesthesia in children: a randomized controlled clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087588
Enrollment
Unknown
Registered
2024-07-30
Start date
2024-08-05
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Saline Group:Normal saline
Esketamine Group:0.5mg/kg esketamine

Sponsors

Guangzhou Women and Children’s Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1) Age between 3-6y, gender is not limited; 2) Laparoscopic day surgery is planned to be performed under general anesthesia using a laryngeal mask airway; 3) ASA anesthesia grade I to II; 4) The parents or legal guardians of the affected child have signed an informed consent form for medical research.

Exclusion criteria

Exclusion criteria: 1) Children with allergies to ketamine and its components; Children with severe thrombocytopenia and gastrointestinal ulcers. 2) Analgesics, sedatives, antiemetics, and antipruritic drugs were used 24 hours before surgery; 3) Children with symptoms of acute upper respiratory tract infection before surgery; 4) Children with a history of bronchial asthma; 5) Children with severe sleep apnea syndrome and arrhythmia; 6) Has a history of abnormal surgical anesthesia recovery in the past; Preoperative assessment of the presence or possibility of difficult airway conditions 7) Renal dysfunction (BUN and/or Cr>upper limit of normal value); Liver function damage (ALT and/or AST>1.5 times the upper limit of normal values); 8) Children who are deemed unsuitable for inclusion by researchers due to other circumstances.

Design outcomes

Primary

MeasureTime frame
LMA removal time;

Secondary

MeasureTime frame
the length of PACU stay;BIS value;

Countries

China

Contacts

Public ContactNa Zhang

Guangzhou Women and Children's Medical Centre

na999666@163.com+86 135 6040 9867

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026